L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter].
作者信息
Dos Santos Victor Augusto Benedicto, Pedrazini Maria Cristina
机构信息
Department of Biosciences, Faculdade de Odontologia de Piracicaba (FOP), Universidade Estadual de Campinas (UNICAMP), Piracicaba, São Paulo State, Brazil.
出版信息
Clin Cosmet Investig Dermatol. 2024 Feb 13;17:433-434. doi: 10.2147/CCID.S461722. eCollection 2024.
Abstract
摘要
相似文献
1
L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter].
Clin Cosmet Investig Dermatol. 2024 Feb 13;17:433-434. doi: 10.2147/CCID.S461722. eCollection 2024.
2
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter].
Clin Cosmet Investig Dermatol. 2024 Feb 24;17:463-464. doi: 10.2147/CCID.S464230. eCollection 2024.
3
L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.
Dermatol Ther. 2021 Jan;34(1):e14679. doi: 10.1111/dth.14679. Epub 2020 Dec 30.
4
Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.
5
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
Dermatol Reports. 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. eCollection 2023 Mar 7.
6
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.
7
Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
Dermatol Ther. 2021 Nov;34(6):e15129. doi: 10.1111/dth.15129. Epub 2021 Sep 25.
8
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Clin Dermatol. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Epub 2022 Jan 31.
9
Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
Dermatology. 2015;230(1):23-6. doi: 10.1159/000368352. Epub 2015 Jan 16.
10
Dermoscopic characterization of guttate psoriasis, pityriasis rosea, and pityriasis lichenoides chronica in dark skin phototypes: An observational study.
Dermatol Ther. 2021 Jan;34(1):e14631. doi: 10.1111/dth.14631. Epub 2020 Dec 13.
引用本文的文献
1
L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter].
Clin Cosmet Investig Dermatol. 2024 Feb 24;17:463-464. doi: 10.2147/CCID.S464230. eCollection 2024.
本文引用的文献
1
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
Clin Cosmet Investig Dermatol. 2024 Jan 8;17:51-57. doi: 10.2147/CCID.S447834. eCollection 2024.
2
L-lysine: Its antagonism with L-arginine in controlling viral infection. Narrative literature review.
Br J Clin Pharmacol. 2022 Nov;88(11):4708-4723. doi: 10.1111/bcp.15444. Epub 2022 Jul 5.
3
Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
Dermatol Ther. 2021 Nov;34(6):e15129. doi: 10.1111/dth.15129. Epub 2021 Sep 25.
4
Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?
J Cosmet Dermatol. 2021 Jun;20(6):1566-1567. doi: 10.1111/jocd.14035. Epub 2021 Mar 8.
5
L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.
Dermatol Ther. 2021 Jan;34(1):e14679. doi: 10.1111/dth.14679. Epub 2020 Dec 30.
6
Interventions for pityriasis rosea.
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.
7
Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis.
An Bras Dermatol. 2018 Sep-Oct;93(5):686-695. doi: 10.1590/abd1806-4841.20187252.
8
The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis.
J Dermatolog Treat. 2019 May;30(3):288-293. doi: 10.1080/09546634.2018.1508820. Epub 2018 Sep 4.
9
Latency, Integration, and Reactivation of Human Herpesvirus-6.
Viruses. 2017 Jul 24;9(7):194. doi: 10.3390/v9070194.
10
Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
Antiviral Res. 2016 Aug;132:13-25. doi: 10.1016/j.antiviral.2016.05.009. Epub 2016 May 15.
Zotero 插件